News

A young boy kneels on a raised surface and reaches out to hug his mother

Scientists on a quest to prevent asthma by boosting immune system

A family history of respiratory illnesses led environmental researcher Paloma Beamer, PhD, to enroll her newborn son in a clinical trial to prevent asthma.

Portrait of Mingyu Liang, MB, PhD, standing outside in front of trees.

Mingyu Liang works to transform physiology at U of A

Onicio Leal Neto, PhD, MPH, stands at a desk next to a table full of people with laptops open in front of them.

Public Health launches first AI summer program

Young adult connecting smartphone to continuous glucose monitor, checking blood glucose

New bachelor’s degree positions students for success in growing medical device industry

Uniquely U of A Health Sciences

Older man with glasses and white hair stands smiling in a lab wearing a white coat.

Paging Dr. Robot: Marvin Slepian on AI in health care

brown bottle labeled methadone with small dose cup

Study seeks to transform methadone treatment for opioid use disorder

human T cell

$13M NIH grant funds research aimed at revitalizing immune systems of older adults

A laboratory table has larg jars labeled "Zombie Virus" along with a couple of skulls and a manikin head with a mask sitting in a bowl.

Halloween spirit haunts the halls of Health Sciences

Graphic with 23 small portraits of medical students in their white coats with the text, "2023 Primary Care Physician Scholarship Recipients."

2023 Primary Care Physician Scholarship recipients

Soldiers crouching down and communicating

$1.5M DOD grant will create virtual reality test to assess TBI in the field

When an astrocyte’s mitochondria (magenta) are impaired, they are unable to break down lipid waste (cyan), and the buildup of extra fat (white spots) might be accelerating the progression of Alzheimer’s disease.

Brain’s self-cleaning machinery may be key to Alzheimer’s

A powerful voice for her students

Comprehensive Center for Pain and Addiction researchers say reclassifying cannabis as a Schedule III substance would loosen the restraints on research into possible benefits, as well as any potential negative side effects, of medical marijuana.

Should cannabis still be a Schedule I drug?

Student-faculty team of inventors devises tools to address orthopedic challenges

John Galgiani, MD

Paving a path for Valley fever research, treatment, prevention

A smiling woman with gray hair holds a plaque as smiling men in dark suites stand on each side of her.

Arizona Telemedicine and Telehealth earn USDLA Gold Award